NDA Uganda: Closes 109 Illegal Drug Outlets, Seizes Shs65m Medicine

• The National Drug and Health Products Authority closed over 109 illegal drug outlets in Eastern Uganda during a week-long operation.
• Enforcement teams seized 260 boxes of assorted medicines valued at more than Shs65 million.
• The operation aimed to stop the sale and distribution of medicines through unlicensed and non-compliant channels.
• The National Drug and Health Products Authority Act, 2026, enacted this year, introduces tougher penalties, including up to two years in prison or a fine exceeding Shs1 billion, or both, for illegal drug distribution.
• The NDHPA urged the public to buy medicines only from licensed pharmacies and to report suspected violations.

This intensified enforcement campaign follows the enactment of the National Drug and Health Products Authority Act, 2026, enacted earlier this year, which introduces significantly tougher penalties for individuals found guilty of offenses related to the illegal distribution of drugs.

The National Drug and Health Products Authority (NDHPA) recently concluded a week-long enforcement initiative, resulting in the closure of more than 109 illicit drug outlets across Eastern Uganda. This targeted operation focused on non-compliant drug dealers operating in the districts of Iganga, Kamuli, Luuka, Bugiri, and Jinja. During the crackdown, enforcement teams successfully confiscated 260 boxes containing various medicines, with an estimated total value exceeding Shs65 million.

The primary objective of this widespread action was to curtail the sale and distribution of pharmaceutical products through channels that lack proper licensing and fail to meet regulatory standards. Abiaz Rwamwiri, spokesperson for the NDHPA, emphasized that such unauthorized practices pose significant risks to public health. These efforts underscore the National Drug and Health Products Authority's commitment to safeguarding the well-being of Ugandan citizens by ensuring the integrity of the medicine supply chain.

The NDHPA's enforcement activities are driven by serious concerns regarding the public health consequences of unregulated medicine distribution. Mr. Rwamwiri highlighted that illegal drug practices expose individuals to substandard medications, inappropriate usage, and potential complications from treatment. He further elaborated that these unauthorized activities contribute directly to the circulation of poor-quality drugs, foster irrational drug use, lead to treatment failures, and exacerbate the critical issue of antimicrobial resistance, collectively presenting substantial public health hazards.

The National Drug and Health Products Authority operates under a broad mandate to protect and advance public health through the stringent regulation of both human and veterinary medicines, alongside other healthcare products. This recent operation in Eastern Uganda is a direct manifestation of that core responsibility. The authority continues to urge the public to exercise caution by procuring medicines exclusively from officially licensed pharmacies and drug shops, and to promptly report any suspected violations related to drug distribution to the regulatory body.

This intensified enforcement campaign follows the enactment of the National Drug and Health Products Authority Act, 2026, enacted earlier this year, which introduces significantly tougher penalties for individuals found guilty of offenses related to the illegal distribution of drugs. Under the provisions of this updated law, offenders now face potential imprisonment for up to two years, a substantial fine exceeding Shs1 billion, or both. This legislative change provides the National Drug and Health Products Authority with enhanced tools to combat illicit pharmaceutical activities and reinforce pharmaceutical compliance Uganda.

For operators whose medicines were impounded during the recent operation, the NDHPA has provided a clear pathway for resolution. They are advised to visit the NDHPA South Eastern Regional Office located in Jinja City to receive guidance on the necessary compliance requirements. This directive aims to facilitate adherence to regulations rather than simply penalizing non-compliance, though the new penalties underscore the seriousness of future infractions. The government's commitment to strengthening drug law penalties Uganda reflects a broader strategy to protect its citizens from the dangers of an unregulated medicine market.

Lawyers advising pharmaceutical companies, distributors, or healthcare providers in Uganda must inform clients about the National Drug Authority's intensified enforcement actions and the new, tougher penalties for non-compliant drug distribution. This necessitates a review of current compliance frameworks and operational practices, especially for businesses operating in Eastern Uganda, to mitigate legal and financial risks.

Source: Original reporting via Nile Post.